Baillie Gifford & CO Sutro Biopharma, Inc. Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

A detailed history of Baillie Gifford & CO transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 1,519,341 shares of STRO stock, worth $3.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,519,341

Previous 1,848,751 17.82%

Holding current value

$3.1 Million

Previous $5.42 Million 2.95%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$2.88 - $5.01 $948,700 - $1.65 Million	-329,410 Reduced 17.82%	1,519,341 $5.26 Million
Q2 2024 Jul 25, 2024	BUY	$2.92 - $5.33 $5,387 - $9,833	1,845 Added 0.1%	1,848,751 $5.42 Million
Q1 2024 May 01, 2024	SELL	$3.27 - $5.65 $65,216 - $112,683	-19,944 Reduced 1.07%	1,846,906 $10.4 Million
Q4 2023 Jan 26, 2024	SELL	$2.07 - $4.54 $1,664 - $3,650	-804 Reduced 0.04%	1,866,850 $8.01 Million
Q1 2023 May 03, 2023	SELL	$4.48 - $8.45 $4,305 - $8,120	-961 Reduced 0.05%	1,867,654 $8.63 Million
Q3 2022 Oct 27, 2022	BUY	$5.17 - $7.11 $17,758 - $24,422	3,435 Added 0.18%	1,868,615 $10.4 Million
Q2 2022 Aug 08, 2022	SELL	$3.41 - $8.95 $11,324 - $29,722	-3,321 Reduced 0.18%	1,865,180 $9.72 Million
Q1 2022 May 05, 2022	BUY	$7.78 - $15.31 $103,092 - $202,872	13,251 Added 0.71%	1,868,501 $15.4 Million
Q4 2021 Jan 20, 2022	BUY	$14.25 - $23.53 $859,417 - $1.42 Million	60,310 Added 3.36%	1,855,250 $27.6 Million
Q3 2021 Oct 19, 2021	BUY	$16.88 - $22.38 $12,946 - $17,165	767 Added 0.04%	1,794,940 $33.9 Million
Q2 2021 Aug 02, 2021	BUY	$18.03 - $23.82 $1.78 Million - $2.35 Million	98,519 Added 5.81%	1,794,173 $33.4 Million
Q3 2020 Nov 12, 2020	BUY	$7.44 - $13.15 $1.46 Million - $2.57 Million	195,654 Added 13.04%	1,695,654 $17 Million
Q2 2020 Aug 12, 2020	BUY	$7.24 - $11.05 $10.9 Million - $16.6 Million	1,500,000 New	1,500,000 $11.6 Million

Others Institutions Holding STRO

# of Institutions

140

Shares Held

62.4M

Call Options Held

77.1K

Put Options Held

31.4K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $106M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Sutro Biopharma, Inc. Transaction History